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ABSTRACT Cl channels play important roles in many physiological processes, including transepithelial ion absorption and
secretion, smooth and skeletal muscle contraction, neuronal excitability, sensory perception, and cell volume regulation. The
molecular identity of many types of Cl channels is still unknown. Recently, three research groups have arrived independently
at the identiﬁcation of TMEM16A (also known as anoctamin-1) as a membrane protein strongly related to the activity of Ca2þ-
activated Cl channels (CaCCs). Site-speciﬁc mutagenesis of TMEM16A alters the properties of the channels, thus suggesting
that TMEM16A forms, at least in part, the CaCC. TMEM16A is a member of a family that includes nine other membrane proteins.
All TMEM16 proteins have a similar structure, with eight putative transmembrane domains and cytosolic amino- and carboxy-
termini. TMEM16B expression also evokes the appearance of CaCCs, but with biophysical characteristics (voltage dependence,
unitary conductance) different from those associated to TMEM16A. The roles of the other TMEM16 proteins are still unknown.
The study of TMEM16 proteins may lead to identiﬁcation of novel molecular mechanisms underlying ion transport and channel
gating by voltage and Ca2þ.
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Ion channels permeable to Cl and other anions are key
proteins of all cells, involved in housekeeping roles such
as cell volume regulation or in more specialized physiolog-
ical functions such as excitability, contraction, and transepi-
thelial electrolyte/fluid transport (1). All these functions are
carried out by a plethora of different Cl channels whose
molecular identity is only partially known. For many years,
studies based mostly on patch-clamp technique have re-
ported the existence of Cl/anion channels characterized
by different biophysical properties, mechanism of regulation,
and pharmacological sensitivity (1,2). Mechanisms of activa-
tion include direct binding by extracellular ligands, elevation
of intracellular Ca2þ, cAMP-dependent phosphorylation,
membrane potential changes (hyperpolarization or depolar-
ization), and cell swelling. A fraction of these channels
have been identified at the molecular level: cystic fibrosis
transmembrane conductance regulator (CFTR) as the
cAMP-activated channel of epithelial cells, gamma amino-
butyric acid (GABA)- and glycine-activated ionotropic
receptors of inhibitory synapses, ClC-1 in skeletal muscle,
ClC-Ka and ClC-Kb of kidney and inner ear, and the ubiqui-
tous ClC-2 (1,2). The identity of other Cl channel types has
remained elusive and quite controversial.
Among these more obscure membrane proteins, Ca2þ-
activated Cl channels (CaCCs) have attracted the attention
of many investigators who have tried to give them a molec-
ular identity (3,4). CaCCs participate in many important
physiological processes, including epithelial fluid secretion,
smooth muscle contraction, and olfactory transduction
(Fig. 1). Previous attempts to identify the CaCC indicated
that CLCA (5), ClC-3 (6), bestrophins (7,8), and Tweety
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0006-3495/09/12/3047/7 $2.00(9) are possible candidates. However, expression of such
proteins generates Cl currents that are actually different
from those of classical CaCCs (3,10). Indeed, one of the
most common characteristics of native CaCCs in many
tissues and cell types is a characteristic voltage dependence
that is modulated by intracellular Ca2þ (3,4,11,12,13). At
nonmaximal Ca2þ concentrations, such CaCC channels are
activated and deactivated by positive and negative mem-
brane potentials, respectively. Consequently, the current-
voltage relationship is outwardly rectifying. With maximal
Ca2þ, on the other hand, the channels are fully activated at
all membrane potentials and the current-voltage relationship
becomes linear. Such properties were not recapitulated by
any of the postulated CaCC candidates. The simplest expla-
nation for this discrepancy is that these candidate proteins
represent different types of Cl channels (e.g., bestrophins)
or no channels at all. For example, it is now believed that
CLCA proteins are actually cell adhesion molecules whose
relationship with Cl channels is indirect (14).
Recently, three research groups have independently
identified TMEM16A as a strong candidate for the CaCC
(15–17).
TMEM16A ENTERS THE SCENE
Yang and colleagues (15) identified TMEM16A by perform-
ing a bioinformatic analysis looking for novel membrane
proteins with more than two transmembrane domains. Heter-
ologous expression of TMEM16A, which was initially
cloned from mouse retina, resulted in the appearance of
Ca2þ-activated Cl channels. Furthermore, silencing of
TMEM16A in vivo caused inhibition of salivary gland secre-
tion, a classical example of a function involving CaCCs (15).
TMEM16A was also found by expression cloning (16). In
fact, expression cloning in Xenopus laevis oocytes is
doi: 10.1016/j.bpj.2009.09.024
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nels, such as ClC-0 (18) and ENaC (19). Typically, this
approach involves the expression in oocytes of large collec-
tions (libraries) of coding sequences derived from a tissue
with high expression of a specific ion channel. The process
is repeated on progressively smaller pools of sequences until
a single clone coding for the searched channel is identified.
This strategy was not possible for CaCCs because Xenopus
oocytes already have a high endogenous expression of these
FIGURE 1 Physiological roles of CaCCs. In epithelial cells, activation of
CaCCs by intracellular Ca2þ elevation leads to Cl secretion followed by
transepithelial transport of Naþ and water. In smooth muscle cells, activation
of CaCCs is part of an amplification mechanism. Intracellular Ca2þ increase
by extracellular stimuli activates CaCCs and Cl efflux. The resulting
membrane depolarization opens voltage-dependent Ca2þ channels that
cause a further intracellular Ca2þ increase, thus potentiating contraction.
Another amplification mechanism occurs in olfactory receptors, where the
initial Ca2þ increase is triggered by cAMP-gated channels. CaCC is also
involved in phototransduction and regulation of neuronal excitability.Biophysical Journal 97(12) 3047–3053channels. However, Schroeder and colleagues (16) realized
that oocytes from a different amphibian, the Axolotl sala-
mander (Ambystoma mexicanum), are devoid of CaCC
activity. This finding paved the way for a classical expres-
sion cloning approach that resulted in the identification
of a novel protein, TMEM16A, as the CaCC channel or a
subunit thereof (16).
In our laboratory, we arrived at the same conclusion
regarding TMEM16A using a functional genomics approach
(17) (Fig. 2). We started from the observation that inter-
leukin-4 (IL-4) upregulates Ca2þ-dependent Cl secretion
in human bronchial epithelial cells (20). These data sug-
gested a mechanism of action based on the upregulation by
IL-4 of the gene coding for CaCCs. Therefore, we performed
a global gene expression analysis by microarrays to identify
genes upregulated by IL-4 and coding for membrane proteins
with unknown function. The microarray analysis identified
TMEM16A as a candidate. TMEM16A was then confirmed
by a combination of experiments involving gene silencing
with siRNA and overexpression by transfection (17).
Interestingly, all three studies reported that heterologous
expression of TMEM16A in different cell types always
generated Cl currents with the classical properties of
CaCCs, e.g., slow activation at positive membrane potentials
and inhibition by niflumic acid, 5-nitro-2-(phenylpropyla-
mino)-benzoate (NPPB), and other CaCC blockers. The
fact that three research teams arrived at the same conclusion
using different strategies seems good evidence in favor of
TMEM16A as a protein strongly related to CaCC activity.
PROPERTIES OF TMEM16A-ASSOCIATED CL
CURRENTS
The most striking feature of the TMEM16A protein is the
consistent finding that its expression in different cell systemsFIGURE 2 Identification of TMEM16A by functional
genomics. Differentiated human bronchial epithelial cells
respond to a 24-h IL-4 treatment with an upregulation of
Ca2þ-depedent Cl secretion, presumably by hyperexpres-
sion of the gene coding for CaCC. Global gene expression
analysis was carried out by microarrays to identify CaCC
candidates, i.e., genes upregulated by IL-4 and coding for
putative membrane proteins with unknown function.
Candidate genes were silenced with siRNA in epithelial
cells with endogenous CaCC activity. Functional analysis
by short-circuit current (Isc) recording across whole
epithelia or by the whole-cell patch-clamp technique
showed that silencing of TMEM16A caused reduction of
CaCC activity.
Biophysical Reviews 3049(HEK-293 and FRT cells and Axolotl oocytes) always leads
to the appearance of voltage-dependent Ca2þ-activated Cl
channels very similar to classical CaCCs (15–17,21). At non-
maximal Ca2þ concentrations, voltage pulses to positive
membrane potentials elicit slow-activating currents. This
effect is reversible, as the return to negative membrane
potentials causes a deactivation of the current. Accordingly,
the steady-state current-voltage relationship under this
condition is outwardly rectifying. However, elevation of
intracellular Ca2þ to micromolar concentrations progres-
sively shifts the voltage-dependent activation of the channel
to negative values. At maximal concentration of Ca2þ, the
channels become fully active at all membrane potentials,
and consequently, the relaxations after voltage steps disap-
pear. Yang et al. found that, similar to the case for native
CaCC channels, the apparent affinity of TMEM16A-associ-
ated Cl channels for Ca2þ is affected by membrane poten-
tial (15). Indeed, the half-effective Ca2þ concentration is
2.6 mM at 60 mV and 0.4 mM at þ60 mV. This property
may be attributable to a Ca2þ-binding site lying within a
region of the protein that senses the transmembrane electric
field. Another possibility is that the affinity of the binding
site for Ca2þ is modified by voltage using an allosteric
mechanism.
Also, the ion selectivity of TMEM16A-associated chan-
nels reported by Yang et al. (15) resembles, at least in part,
that of CaCC channels. In particular, cells expressing
TMEM16A show channels with the following permeability
sequence to anions: NO3
 > I > Br > Cl > F (15).
This sequence is similar, although not identical, to that re-
ported for native CaCCs (3,22,23). Interestingly, Schroeder
et al. report that the channels induced by TMEM16A expres-
sion do not have a fixed ion selectivity (16). Rather, the ion
permeability changes within the same cell depending on the
state of channel activity. This finding suggests the existence
of multiple open states of the channel, each characterized by
a different degree of ion selectivity.
A third parameter to describe Cl channels is their sensi-
tivity to pharmacological modulators. Compared to cation
channels, most Cl channels suffer from a relative lack of
specific inhibitors or activators (1,2). However, there is a
panel of inhibitors that may be used to generate a fingerprint
of pharmacological sensitivity for each Cl channel. For
example, CaCCs are typically blocked by niflumic acid
and NPPB at low micromolar concentrations (3). NPPB
and niflumic acid, but not the selective CFTR inhibitor-
172, strongly inhibit TMEM16A-dependent Cl channels
(17). The only discrepancy is in the case of tamoxifen,
a poorly specific channel inhibitor. This compound was re-
ported to be active by Yang and colleagues (15), but
Schroeder and co-workers (16) found it to be inactive.
Regarding the mechanism of regulation, TMEM16A-
dependent Cl channels appear to be activated by all exper-
imental maneuvers that result in an intracellular Ca2þ
increase (15–17). Such maneuvers include intracellular dial-ysis with a high-Ca2þ solution utilizing a patch-clamp
pipette, stimulation with a Ca2þ ionophore, receptor-medi-
ated Ca2þ elevation, or perfusion of the cytosolic side of
membrane patches during inside-out patch-clamp record-
ings. These findings clearly indicate that TMEM16A-depen-
dent channels are activated by Ca2þ, but they do not clarify
the mechanism through which Ca2þ activates the channels.
Actually, this is an unresolved issue also for native CaCCs
(3). Indeed, various studies have arrived at discrepant results.
It has been reported that CaCCs are activated through
calmodulin (24), or by means of Ca2þ-dependent phosphor-
ylation (25,26). In smooth muscle cells, phosphorylation has
even an inhibitory mechanism (27,28).
STRUCTURE-FUNCTION OF TMEM16A
(OR, IS TMEM16A A CHANNEL?)
TMEM16A is part of a family of proteins that includes nine
other members named as TMEM16B-K (29). The primary
sequence identity is relatively high for TMEM16B (~60%)
but decreases progressively with the other TMEM16
proteins, so that TMEM16F, G, H, J, and K are only
20–30% identical. All TMEM16 proteins have a similar puta-
tive topology, consisting of eight transmembrane segments
and cytosolic N- and C-termini (Fig. 3). Because of this
topology and their role in anion transport, TMEM16 proteins
were recently named anoctamins. Interestingly, the trans-
membrane segments are the regions of TMEM16 proteins
showing maximal conservation. For example, the sequence
of the putative sixth transmembrane domain of human
FIGURE 3 Structure of TMEM16A protein. The protein has eight puta-
tive transmembrane domains and intracellular N- and C-termini. Various
isoforms are generated by inclusion or skipping of four alternative segments
labeled a (116 residues), b (22 residues), c (4 residues), and d (26 residues).
The full protein, TMEM16A(abcd), containing all four segments, is 1008
amino acids long. The sequence of segments b, c, and d is shown. Colored
circles show amino acids whose mutagenesis leads to alteration of ion
channel properties (voltage dependence and/or ion selectivity). Blue circles,
R563 and Q757 in the third and sixth transmembrane domains (17); red
circles, R669, K693, and K716 (R621, K645, and K668 in Yang et al.
(15)). According to results obtained for these three amino acids (15), the
region between the fifth and sixth transmembrane domains may not be
entirely extracellular, as shown in the figure, but may form a reentrant
loop that constitutes part of the channel pore.Biophysical Journal 97(12) 3047–3053
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of TMEM16K (anoctamin-10, ANO10). However, the
sequence identity decreases to ~20% when the protein is
considered as a whole. The region between the fifth and sixth
transmembrane segments, instead of being fully extracellular,
as shown in Fig. 3,may form a reentrant loop important for the
formation of the channel pore. Indeed, mutagenesis of posi-
tively charged amino acids localized in this region altered
ion selectivity of the channels, thus enhancing their perme-
ability to cations (15). Altered ion selectivity and voltage
dependencewere also observed bymutagenesis of an arginine
and a glutamine in the third and sixth transmembrane
domains, respectively (17) (Fig. 3). These results suggest
that various regions of the TMEM16A protein are directly
or indirectly involved in determining the properties of
Ca2þ-activated Cl channels.
Another interesting characteristic of the TMEM16A
protein is the presence of multiple isoforms that originate
by alternative splicing (17). We have described the existence
of a basic minimal isoform, termed TMEM16A(0), formed
by 840 residues and containing all putative transmembrane
segments. This structure can be expanded by addition/inclu-
sion of four alternative regions called segments a (116 resi-
dues), b (22 residues), c (4 residues), and d (26 residues)
(Fig. 3). Segment a is added at the N-terminus, thus extend-
ing the cytosolic portion of the protein. Segment b is
included before the first transmembrane domain. Segments
c and d are instead localized in the first intracellular loop con-
necting the second and third transmembrane domains. It is
worth noting that TMEM16A(0) is functional and able to
transport anions (17). However, in contrast to other isoforms,
such as TMEM16A(abc) and TMEM16A(abcd), it is devoid
of voltage-dependent activation. This finding suggests that
alternative splicing is a mechanism to regulate channel prop-
erties and may be the basis for generation of different CaCC
types with different voltage dependence and Ca2þ sensi-
tivity.
Interestingly the studies carried out so far on TMEM16A
have not led to the clarification of the mechanism of activa-
tion by Ca2þ. The TMEM16A sequence does not clearly
show similarity to known domains involved in direct Ca2þ
binding (e.g., EF-hands) or motifs suggesting binding to
calmodulin. It is possible that either Ca2þ dependence is
mediated by another protein or TMEM16A has noncanonical
domains involved in regulation by Ca2þ. In this respect, we
can hypothesize that regions of TMEM16A protein rich in
negatively charged residues are involved in Ca2þ binding.
For example, there is a cluster of four glutamic acid residues
in the first intracellular loop connecting the second and third
transmembrane domains, right before the site of insertion of
segment c. Actually, inclusion of the microexon correspond-
ing to segment c adds a fifth glutamic acid residue. This
concentration of negative charges may resemble the Ca2þ
bowl of large-conductance Ca2þ-activated Kþ channels
(30). However, we have to consider that coordination ofBiophysical Journal 97(12) 3047–3053Ca2þ ions may also involve the carbonyls of the peptidic
backbone. Therefore, the site for Ca2þ binding may not be
easily predicted. Demonstration that TMEM16A is a Ca2þ-
regulated molecule may require extensive mutagenesis
studies spanning large sections of the whole protein.
In summary, the high similarity between TMEM16A-
dependent currents and CaCCs suggests that the TMEM16A
protein is a channel. However, although the data obtained so
far are exciting and encouraging, it is important to be
cautious, particularly considering previous claims about
other membrane proteins as Cl channels. In fact, various
scenarios are still possible. TMEM16A may be the only
protein needed to form the CaCC channel, or it may be
just part of the channel, thus requiring assembly with other
proteins yet to be identified. Finally, although this is less
likely, we cannot exclude entirely the possibility that
TMEM16A is not actually part of the channel but is instead
required for activating or trafficking of the real CaCC. As an
example, we cite the STIM-1 protein (31), which is impor-
tant for the function of the Ca2þ channel activated by store
depletion. By sensing the endoplasmic reticulum Ca2þ
content, STIM-1 works as a regulator of the real channel
represented by the Orai-1 protein (32).
It is not simple to define absolutely the criteria needed to
conclude that a given membrane protein is an ion channel.
Alteration of intrinsic ion channel properties by site-specific
mutagenesis is considered a good proof that a given protein
is an ion channel. Actually, as stated above, amino acid
changes in the sequence of TMEM16A have resulted in
the modification of voltage dependence and ion selectivity
of the associated Cl channels (15,17). These findings
suggest that mutations directly alter the structure and func-
tion of the pore and of the voltage sensor of the CaCC
channel. However, considering the small number of sites
that have been mutated so far, it is still possible that the
observed effects are caused by intramolecular or intermolec-
ular allosteric mechanisms. Actually, Schroeder et al. have
suggested the existence of multiple open-channel states,
each characterized by a different ion selectivity (16). If this
is the case, mutations of sites involved in channel gating
may lead to an alteration of the apparent ion selectivity of
macroscopic currents, thus leading to the erroneous conclu-
sion that those sites form the channel pore.
It is probable that progressive accumulation of mutagen-
esis studies from various laboratories will provide further
evidence for TMEM16A as a CaCC channel. Also, reconsti-
tution of TMEM16A protein in cell-free artificial membranes
may be a way to demonstrate the ion channel function. These
and other types of studies will need also to clarify whether the
CaCC is a TMEM16A monomer, a TMEM16A homo-olig-
omer, or a heteromultimeric complex formed by TMEM16A
in combination with other proteins (possibly of the TMEM16
family). In the latter case, tissue-specific differences in the
assembly of CaCCs could account for the wide variety of
CaCC properties reported in many studies.
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The probable role of TMEM16A as an ion channel suggests
that the other TMEM16 proteins are also involved in ion
transport. Indeed, Schroeder et al. showed that heterologous
expression of TMEM16B elicits the appearance of Ca2þ-
activated Cl currents (16). This finding was later confirmed
by three other groups (33–35). In particular, TMEM16B
(anoctamin-2) is expressed in photoreceptors (33) and in
the cilium of olfactory cells (35), where it appears to play
a special role in sensory transduction.
Interestingly, TMEM16B shows some significant func-
tional differences compared to TMEM16A. The channels
associated with TMEM16B have a unitary conductance
~10-fold reduced relative to TMEM16A: 0.8 pS vs 8.3 pS
(15,35). Also, TMEM16B expression evokes Cl currents
that have kinetics faster than those of TMEM16A. Under
conditions of nonmaximal activation by Ca2þ, membrane
depolarization elicits TMEM16B-dependent currents that
rapidly increase, reaching a new steady state in <50 ms.
The time constant for current activation at þ100 mV is
only 4 ms (34). In contrast, TMEM16A-dependent currents
show, upon depolarization, a slow activation that takes
hundreds of milliseconds to stabilize (16,17). Finally,
TMEM16B is less Ca2þ-sensitive. The half-effective Ca2þ
concentrations for TMEM16B and TMEM16A at positive
membrane potentials are in the micromolar and the nanomo-
lar ranges, respectively (15,34,35). It appears also that the
apparent Ca2þ affinity for TMEM16B is less affected by
membrane potential than that of TMEM16A (34,35). For
example, the half-effective Ca2þ concentration for
TMEM16B is 4.9 mM at 50 mV and 3.3 mM at þ50 mV
(34). In contrast, TMEM16A shows a near-sixfold difference
in apparent Ca2þ affinity when changing the membrane
potential to a similar extent (15). The permeability sequence
for anions measured for TMEM16B-dependent currents is
SCN > I > NO3
 > Br > Cl (34).
Differences in the properties of the currents associated
with TMEM16A and TMEM16B may be very useful in
understanding the structure-function relationship. Compar-
ison of the primary structure of the two proteins, by demon-
strating similarity or divergence, may lead to identification of
the domains involved in Ca2þ dependence, voltage sensi-
tivity, and anion transport.
So far, much less is known for the other TMEM16
proteins. According to databases, TMEM16C is particularly
expressed in the nervous system but there are no indications
about its physiological role. TMEM16E (anoctamin-5), also
known as GDD1, is mutated in a human genetic disease
called gnathodiaphyseal dysplasia, a possible calcification
disorder of the bone (36). TMEM16F and TMEM16K
have ubiquitous expression, whereas TMEM16G seems
specifically expressed in prostate. Among all TMEM16
proteins, TMEM16H is the one with the most intriguing
structural characteristics. The region between the fifth andsixth transmembrane domains is rich in negative charges.
In particular, it contains a stretch of 20 contiguous residues
of glutamic and aspartic acid. The cytosolic carboxy-
terminus is instead extremely abundant in prolines (56 out
of 282 total residues).
We do not know at the moment whether the TMEM16
proteins, other than TMEM16A and TMEM16B, are also
associated with Cl channels. It is possible that they repre-
sent different types of ion channels activated by other types
of physiological stimuli. There is still a plethora of anion
channels whose molecular identity remains to be clarified.
Probably the most wanted protein in this field now is the
volume-regulated anion channel (VRAC, also known as
VSOAC). This channel was previously associated with other
proteins such as the P-glycoprotein, ClC-3, and pICln, but its
molecular identity has actually remained unresolved (1). It is
tempting to postulate that VRAC is related to one of the
proteins of the TMEM16 family, an hypothesis that is worth
being tested in future studies.
PERSPECTIVES
The clarification of the physiological role of TMEM16
proteins will probably benefit from the development and
study of animal models. A knockout mouse for TMEM16A
is already available (37). Actually, it was generated even
before knowing the involvement of TMEM16A in ion trans-
port. Interestingly, this animal shows a severe phenotype
characterized by altered formation of tracheal cartilage rings
(37). This alteration probably causes a tracheal collapse and
suffocation of the animal at early stages after birth. However,
it is probable that careful examination of these animals will
reveal further alterations in other organs. At the moment,
the reason for tracheal cartilage abnormalities is unknown.
The TMEM16A knockout mouse shows also a strongly
reduced Ca2þ-dependent Cl secretion and accumulation
of mucus in the airways (38,39). The former defect supports
the role of TMEM16A as a Ca2þ-activated Cl channel in
epithelial cells. The latter defect is instead a tantalizing
finding suggesting that the phenotype of TMEM16A
knockout mice mimics, at least in part, the lung disease of
cystic fibrosis (CF) patients. CF is a severe genetic disease
caused by mutations that impair the function of the CFTR
epithelial Cl channel (40). CFTR loss of function causes
an imbalance in ion/fluid transport, resulting in severe dehy-
dration of the airway surface, accumulation of mucus, and
colonization of the airways by antibiotic-resistant bacteria
(40). It is well known in the CF field that CFTR knockout
mice have no CF-like disease in their lungs. This character-
istic has been explained by postulating that CFTR knockout
mice have a Cl channel whose activity may compensate for
the lack of CFTR. It is possible that TMEM16A is that
channel. Indeed, the absence of TMEM16A function in
knockout mice significantly impairs mucociliary transport
(39). Therefore, TMEM16A has an important role in theBiophysical Journal 97(12) 3047–3053
3052 Galiettaphysiology of airway epithelium and is a possible pharmaco-
logical target to circumvent the Cl transport defect in CF
patients.
TMEM16A is also a potential drug target for other human
diseases. The role of CaCCs in smooth muscle contraction is
the rationale to look for TMEM16A modulators as possible
drugs for the treatment of asthma, hypertension, and gastro-
intestinal motility disorders. However, to avoid undesired
side effects, developers of new drugs targeting TMEM16A
have to take into account its expression and role in many
tissues and organs. The profiling of alternative splicing in
different tissues and the characterization of pharmacological
sensitivity of the various TMEM16A isoforms may help to
design tissue-specific drugs.
Another intriguing characteristic of TMEM16 proteins,
and of TMEM16A in particular, is their overexpression in
human cancers. In fact, TMEM16A was already known to
oncologists by various names—DOG-1, ORAOV2, and
TAOS-2—because of its high expression levels in various
tumors, particularly of the gastrointestinal tract (41–43).
The relationship between cancer and a protein with a role in
Cl transport is not clear. CaCCs may be important in prolif-
eration, migration, and resistance of cancer cells to apoptotic
stimuli. In such a case, TMEM16Amay become an important
target for antitumor therapies. However, we cannot exclude
the possibility that overexpression of TMEM16A derives
from amplification of the chromosomal region containing
the gene (11q13). This event may be favored because the
same region contains other genes involved in cancer cell
survival, proliferation, and invasiveness.
In conclusion, the identification of TMEM16A and
TMEM16B as possible Ca2þ-dependent Cl channels is an
exciting novelty in the field of ion transport physiology
and membrane protein biophysics. Investigation of the struc-
ture-function relationship may reveal novel molecular mech-
anisms and domains developed by nature to transport ions
across the plasma membrane and to sense changes in
membrane potential and cytosolic Ca2þ concentration. The
prospect of defining the role of the other TMEM16 proteins
is similarly interesting. It is possible that these proteins repre-
sent other types of ion channels. Alternatively, as found for
ClC proteins, it is possible that the TMEM16 family includes
members with different functions (44). Some may be chan-
nels, whereas others may be transporters or have unexpected
properties.
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